Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: RSV Immunogenicity Study in the Elderly (RISE) [Phase 3]
A Phase 3 immunogenicity study evaluating an RSV vaccine in elderly participants is currently recruiting. The trial aims to assess immune re…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy
A clinical trial update on Pfizer's ABRYSVO maternal RSV vaccine during pregnancy, focusing on its impact and effectiveness.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults [Phase 1]
Phase 1 study of VXB-241, an RSV-HMPV bivalent vaccine, conducted by Vicebio Australia Proprietary Limited. The trial's listed population is…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults [NA]
This study tests community-based strategies to increase uptake of the RSV vaccine among Latino adults and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older [Phase 2]
Phase 2 study describing the safety and immunogenicity of the IN006 respiratory syncytial virus vaccine in healthy adults aged 60 and older;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
Yale University is conducting a clinical study to assess real-world effectiveness of perinatal respiratory syncytial virus immunoprophylaxis…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Antibiotic Therapy in Viral Airway Infections [Phase 4]
This is a Phase 4 clinical trial evaluating antibiotic therapy for viral airway infections, including influenza and Respiratory Syncytial Vi…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults [Phase 1]
This document describes an early-phase, first-in-human safety and immunogenicity study of the vaccine candidates SCB-1022 and SCB-1033 in he…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults [Phase 3]
A Phase 3 clinical trial is evaluating the immunogenicity and safety of the mRNA-1345 RSV vaccine in high-risk adults. The trial status is a…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) [Phase 1, Phase 2]
This clinical trial update reports on Phase 1/2 studies testing two doses of PRS CK STORM to calm cytokine storms in ARDS caused by SARS-CoV…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
This clinical trial in Japan investigates how respiratory virus infections affect emergency admissions, focusing on Respiratory Syncytial Vi…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China
A clinical trial registry entry describing a surveillance study of respiratory syncytial virus (RSV) in acute respiratory infections among c…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. [Phase 2]
The Phase 2 study of EDP-938 for respiratory syncytial virus infection in high-risk, non-hospitalized adults has completed.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. [Phase 3]
Phase 3 international adaptive platform trial in Europe evaluating two RSV prevention options—maternal vaccine during pregnancy and an infan…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
A clinical trial in France is recruiting infants to evaluate prevention strategies for Respiratory Syncytial Virus (RSV) infections. The stu…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Assessing the Burden of Respiratory Syncytial Virus (RSV)
A clinical trial sponsored by Abu Dhabi Health Services Company is assessing the burden of Respiratory syncytial virus infection and related…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIVIDUALS IN LUSAKA, ZAMBIA
Clinical trial enrolling to surveil, assess, and detect influenza-associated respiratory infections in HIV-positive and HIV-negative individ…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years [Phase 1]
Phase I first-in-human study evaluating safety and tolerability of EuRSV in healthy adults aged 19–80. The trial status is active but not re…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants
A repeated cross-sectional study sponsored by Sanofi Pasteur to determine respiratory syncytial virus immunization rates in German infants. …
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)
This trial analyzes upper respiratory tract immune responses in older adults who are infected or colonized with Streptococcus pneumoniae, to…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults [Phase 1]
This entry describes a Phase 1 study evaluating the safety and immunogenicity of revaccination with SCB-1019T in healthy adults for respirat…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® [Phase 1]
A Phase 1 study evaluating ProTrans for treating respiratory complications associated with COVID-19, influenza A, human metapneumovirus, and…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo. [Phase 4]
This Phase 4 clinical trial in South Africa evaluates maternal safety and infant protection against RSV lower respiratory tract infection wh…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants
A completed clinical study sponsored by Shionogi examining how respiratory syncytial virus infection develops and changes over time in pedia…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults [Phase 1]
Phase 1 safety and immunogenicity trial update for LYB005 RSV vaccine in healthy adults; trial status is ACTIVE_NOT_RECRUITING.